Latest News & Updates

Breaking News

  • 9 hours ago

  • Team Pharma Now

Biologics X 3DCC Conference 2026: Merging Innovation, Drug Development, and Translation for the Next Era of Biopharma – Registrations OPEN!
Breaking News
ErlySign Successfully Completes Large-Scale Clinical Trial Across India; Poised to Launch its Oral Detection Kit by April 2026

Team Pharma Now

Other trending news you may like to read

Biologics X 3DCC Conference 2026: Merging Innovation, Drug Development, and Translation for the Next Era of Biopharma – Registrations OPEN!

Mumbai Biocluster announces Biologics X 3DCC Summit 2026, uniting biologics and 3D cell culture leaders to accelerate next-gen biopharma innovation.

Team Pharma Now

Pharma Now

ErlySign Successfully Completes Large-Scale Clinical Trial Across India; Poised to Launch its Oral Detection Kit by April 2026

ErlySign completes a 1,000-patient clinical trial for India’s first salivary biomarker test for early oral cancer, targeting market launch in 2026.

Team Pharma Now

Pharma Now

Cartesian Therapeutics Appoints Biopharma Veteran Dr. Adrian Bot To Board Of Directors, Adds Expertise In CAR T, RNA-Based Medicines, And Cell Therapy Innovations

Cartesian names industry veteran Adrian Bot to its Board of Directors, adding deep expertise in CAR T, RNA, and immune therapies.

Simantini Singh Deo

Pharma Now

Alvotech And Teva Secure U.S. Settlement Date For AVT06, Proposed Biosimilar To Eylea®, Targeting Q4 2026 Launch

Alvotech and Teva secure a U.S. settlement with Regeneron, paving the way for AVT06 Eylea biosimilar launch in 2026.

Simantini Singh Deo

Pharma Now